News

JRC Science for policy e-learning course

Published on | 4 years ago

Programmes JRC

The JRC e-learning course on Science Policy is now open for registration on the new EU Academy platform.

The course is designed for researchers who would like their research results to have greater policy impact, but may not have the know-how to communicate effectively with policymakers.

The Science for Policy e-learning course provides the skills that researchers need to increase the impact of their research results on policy and society at large. Designed for early to mid-career researchers, the course equips participants with state-of-the art knowledge and best practice examples from the field. Participants engage in interactive games and self-assessments to gauge their progress. The 60 minutes course can be followed at the learner’s convenience and own pace.

You can find the link to the course here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1589 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.